GREM1 delivered by mesenchymal stem cells (MSCs) was overexpressed in esophageal squamous cell carcinoma (ESCC), leading to enhanced EMT via TGF-β/BMP signaling [53]. The gene discussed is GREM1; the disease is esophageal squamous cell carcinoma.